ID
27673
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
Versions (2)
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 26, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Contact #2 Year 2 GSK study Prostatic neoplasms NCT00883909
Visit 7 GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Weight
Data type
float
Measurement units
- kg
Alias
- UMLS CUI [1]
- C0005910
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
text
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
text
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
integer
Measurement units
- bpm
Alias
- UMLS CUI [1]
- C0018810
Description
Central Laboratory (Non fasting samples)
Alias
- UMLS CUI-1
- C0022885
Description
Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.
Data type
text
Alias
- UMLS CUI [1]
- C0022885
Description
Date samples taken
Data type
date
Alias
- UMLS CUI [1]
- C1302413
Description
Adverse events Concomitant medications
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C2347852
Description
Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.
Data type
text
Alias
- UMLS CUI [1]
- C2347852
Description
Record details of any new non-serious adverse events / serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events in the appropriate Non-Serious Adverse Events / Serious Adverse Events section.
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Pedal Oedema
Alias
- UMLS CUI-1
- C0574002
Description
Investigational Product
Alias
- UMLS CUI-1
- C0304229
Description
Start Date
Data type
date
Alias
- UMLS CUI [1]
- C0808070
Description
Stop Date
Data type
date
Alias
- UMLS CUI [1]
- C0806020
Description
Dose
Data type
text
Measurement units
- mg
Alias
- UMLS CUI [1]
- C3174092
Description
IP Container No
Data type
text
Alias
- UMLS CUI [1]
- C0180098
Description
Compliance
Alias
- UMLS CUI-1
- C1321605
Description
Total number of Tablets Dispensed
Data type
text
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Description
Total number of Tablets Returned
Data type
text
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Compliance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0013227
Similar models
Visit 7 GSK-AVA100468 NCT00381238
- StudyEvent: ODM
C2347852 (UMLS CUI-2)
C0456389 (UMLS CUI [1,2])
C0441987 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])